Pre- Vs Postoperative Thromboprophylaxis for Liver Resection

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1012 participants.

Also called NCT04731558

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 1,012 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04731558
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Finland, Norway (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04731558. Randomized; triple masking; primary purpose prevention. Start 2021-02-10 (actual); primary completion 2027-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pre- Vs Postoperative Thromboprophylaxis for Liver Resection
Acronym
PREPOSTEROUS
Condition
Liver Cancer
Condition
Surgery
Condition
Thrombosis, Deep Vein
Condition
Embolism, Pulmonary
Condition
Bleeding
Intervention (Drug)
enoxaparin or tinzaparin or dalteparin
Intervention (Drug)
No intervention
Lead sponsor
Helsinki University Central Hospital (class: other)
Collaborator
Academy of Finland (class: other)
Collaborator
The Finnish Medical Association (class: other)

Record details

Record id
cardio:ct-nct04731558
Content hash
9a06b0dc6b6f015808e0d48abf0feca83a25c24b821ba21e4b2db4fb9f0f191b